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Otorhinolaryngologic manifestations are common in 22q11.2 deletion syndrome (22q11.2DS),
but poorly described. This study aimed to better define the ear-nose-throat (ENT) phenotype of
22q11.2DS patients, in the attempt to best detect subjects requiring subspecialist intervention.
We enrolled 25 patients affected with 22q11.2DS. Anatomic and functional ENT findings were
investigated using clinical, laboratory, and instrumental data. Immunophenotype and frequency
of infections were evaluated. Univariate and multivariate analyses were performed. ENT anoma-
lies were found in 88% of patients, and in 20% congenital palate defects required surgery.
Adenoid or palatine tonsil hypertrophy was noted in 80% and 48%. Forty-eight percent of
subjects had rhinolalia/phonia, severe in half of these. We also found nasal regurgitation or
laryngeal penetration/aspiration in 20% and 16%, respectively. Instrumental exams revealed a
mild conductive hearing loss in 32% (bilateral in most cases), tympanometric anomalies in 28%,
and swallowing abnormalities in 16%. Statistical univariate analysis showed a direct association
between rhinolalia/phonia and episodes of laryngeal aspiration (p = .016) and between tympa-
nometric anomalies and increased adenoid volume (p = .044). No association between episodes
of food aspiration and palatal anomalies was found. Moreover, no statistically significant
association was observed between the number of airway infections and the ENT findings. This
study contributes to better define the ENT phenotype in patients with 22q11.2DS, helpful to
prevent potential complications. Furthermore, the identification of a subcategory of patients
may allow the early adoption of specific speech therapy programs to improve the clinical out-
come of 22q11.2DS patients.
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1 | INTRODUCTION
Chromosome 22q11.2 deletion syndrome (22q11.2DS) occurs in
approximately 1:4,000 live births (Devriendt, Fryns, Mortier, van
Thienen, & Keymolen, 1998; Tezenas Du Montcel, Mendizabai, Ayme,
Levy, & Philip, 1996). The phenotype of this syndrome is complex and
the clinical expression is highly variable. Major clinical features include
conotruncal cardiac defects, neonatal hypocalcemia due to hypopara-
thyroidism; immunodeficiency due to thymic a/hypoplasia, recurrent
respiratory infections, facial anomalies, intellectual disability, and
speech delay. Renal, skeletal, and gastrointestinal anomalies may also
be observed (Aloj et al., 2012; Cirillo et al., 2015; Giardino et al., 2014;
Kobrynski & Sullivan, 2007; McDonald-McGinn et al., 1999;
McDonald-McGinn & Sullivan, 2011; McDonald-McGinn et al., 2001).
Psychiatric or autoimmune disorders may also be part of the clinical
phenotype, in particular in older subjects (Bassett et al., 2005). The
22q11.2DS also includes ear-nose-throat (ENT) manifestations, whose
variable expressivity has been poorly characterized so far.
Palatal abnormalities have been reported in more than half of the
subjects, and the most common of these is velopharyngeal incompe-
tence (VPI). The pathogenesis of this condition is multifactorial, being
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linked to anatomical anomalies, and/or to functional alterations. Some
patients exhibit submucosal cleft palate or bifid uvula, whereas overt
cleft palate and cleft lip/palate are less common. Furthermore, most
22q11DS patients have speech or language difficulties related to
velopharyngeal and palatal defects, which may present as hypernasal
speech or increased nasal resonance (Ford, Sulprizio, & Rasgon, 2000;
McDonald-McGinn et al., 1997). Bilateral conductive hearing loss is
frequently reported, especially in subjects with recurrent acute bacte-
rial or secretory otitis media. It is hypothesized that the anatomical
and functional defects of palate and of Eustachian tube, in association
with the immune deficiency, may contribute to the conductive loss.
Only 15% of the patients have sensorineural hearing loss (Bassett
et al., 2005; Digilio et al., 1999; Ryan et al., 1997; Verheij et al., 2017).
Abnormalities of the oropharyngeal and/or crico-esophageal
swallowing phases are further features of 22q11.2DS children and
can be responsible for dysphagia, leading to failure to thrive, and
aspiration-based infections (LaMantia et al., 2016; Ryan et al., 1997).
The purpose of this study is to describe in detail the ENT pheno-
type of 22q11.2DS patients, in the attempt to identify functional
implications of the anatomical alterations and their possible role in
determining susceptibility to infections, and to highlight the otolaryn-
gological anomalies that best identify patients to be referred for a sub-
specialty intervention.
2 | MATERIALS AND METHODS
We conducted a prospective study at a single Italian tertiary reference
Center for Immunodeficiencies. Patients enrolled into the study were
diagnosed as affected with 22q11.2DS by molecular analysis, and had
an age greater than 3 years. Historical, clinical, laboratory, and instru-
mental data were collected for every subject. Informed consent was
obtained from all patients or guardians.
Oropharingoscopy was used to define the palatine tonsils volume
according to Brodsky’s modified classification (Brodsky, 1989), and to
establish the characteristics of the palate and its morphofunctional
abnormalities (Finkelstein, Hauben, Talmi, Nachmani, & Zohar, 1992).
The videonasopharyngoscopic examination was performed by flexible
endoscope. When a reduced collaboration limited the execution of
this exam, the data were integrated with oropharyngoscopic static
and dynamic findings for the classification of any morphofunctional
palatal anomalies and with videofluoroscopic findings for the classifi-
cation of the adenoids volume, according to the Cassano modified
classification (Cassano, Gelardi, Cassano, Fiorella, & Fiorella, 2003).
The classification of nasal air emission was based on the perceptual
relief of air emission during the articulation of plosive, fricative, and
affricate phonemes (Kummer, 2016) integrated with the evaluation of
Glatzel mirror test and of the acoustic timbre variation produced by
the examiner’s occlusion of nostrils during the verbal articulation. A
vocal record of standard words/phrases in Italian with fricative, affri-
cate, and plosive consonants was collected in all patients. The record
was obtained through the Voice Analysis module of the digital pro-
gram Daisy 3.6.13 (Biomedica Amplifon, Italy). This examination aimed
to grading the articulatory alterations according to Massari modified
classification (Motta & Cesari, 1996).
A videofluoroscopic study of swallowing was performed in all
patients. The examination also included the evaluation of the adenoid
volume, in those cases where nasopharyngoscopy was not possible.
Routine audiometric and tympanometric exams were performed by
standard procedures.
A phoniatrist was dedicated to the classification of objective find-
ings including palatal abnormalities, otoscopic findings, tonsils, and
adenoids volume, the latter in conjunction with the radiologist who
conducted the videofluoroscopic examination. The recorded voice
samples were analyzed by three experienced speech specialists
independently for the grading of rhinolalia/rhinophonia.
The obtained data were classified by a semi-quantitative scale in
which the increasing score indicated a progressively more severe
clinical, morphological, and/or functional condition.
The immunophenotype (lymphocyte cells count, lymphocyte
subset cells count, serum levels of immunoglobulin, isohemagglutinins,
and antigen-specific antibodies following immunization) was evalu-
ated in every subject.
The infections of the last 24 months were detected in all patients,
considering those diagnosed at our Center and by the primary care
physician, according to guidelines; we included infections of the ENT
district (otitis, pharyngitis, and sinusitis) and of the lower respiratory
tract. None of the patients underwent prophylactic antibiotic therapy
or immunoglobulin replacement therapy.
As for the statistical analysis, in a first step, we examined the
association between each pair of variables. Associations between con-
tinuous variables were examined by using Spearman rank correlation
test or Pearson correlation test. The level at which results were
defined as being statistically significant was set at a p value of less
than .05. In a second step, we performed a hypothesis-free multi-
variate analysis, using factor analysis. This method divides total data
variability into key components to explain the largest amount of
variability in the data. Factors contributing to the same component
are considered to be associated with each other. A scree plot was
used to select the appropriate number of components for evaluation.
The size of each variable’s contribution to each factor can be deter-
mined by the factor loading size. A loading of 0.7 or greater indicates
that a variable was associated with that component. A varimax
rotation was used to enable a clearer interpretation of the results.
Variables showing distribution to be highly skewed were analyzed on
the log scale. The calculations were performed using IBM SPSS Statis-
tics, v.20.0 software (IBM Corp. Armonk, NY).
3 | RESULTS
Our cohort of patients, as illustrated in Table 1, included 25 subjects
(16 males); of these, 9 subjects are aged between 4 and 8 years,
10 between 9 and 13 years, 6 between 14 and 21 years. No patient
was affected by Complete DiGeorge syndrome (ESID Diagnostic
criteria) and approximately 76% of the subjects had a cardiac cono-
truncal defect.
The patients have been investigated about a number of anatomi-
cal and functional otolaryngological features, as detailed in Table 2.
Twenty percent of the subjects had congenital palatal abnormalities
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requiring surgery, including submucous cleft palate, cleft velum, and
cleft palate.
Overall, palatal abnormalities affected 21 of the 25 patients
(84%): more than half of them (56%) had occult submucous cleft
palate, while 20% of the subjects had a hypomobile palate, and 8%
had an immobile palate. The otological exam showed normal tympanic
membranes in 16 of the 25 patients (64%), bilateral retracted
tympanic membrane in 8 of 25 (32%), and bilateral tympanic effusion
in 1 subject (3.8%). As for the palatine tonsils volume, 13 of the
25 patients (52%) had tonsils not exceeding the pillars, 10 patients
(40%) had tonsils up to 50% of the space between loggia and median
line, and 2 patients (8%) had tonsils up to 75%. Moreover, 5 of the
25 patients (20%) had adenoids occupying up to 25% of the nasophar-
ynx, 15 (60%) had adenoids occupying up to 50% and 5 (20%) had
adenoids occupying up to 75% of the nasopharynx. As for the
presence of rhinolalia/rhinophonia, 13 subjects (52%) had normal
articulation, 7 (28%) had some typical slight articulatory defects with
mild/moderate open rhinophonia (hypernasality), and 5 (20%) had
constant articulatory defects with moderate/severe open rhinophonia.
About the study of nasal air emission, audible inconsistent nasal emis-
sion in 7 cases (28%) and audible consistent nasal emission in 6 out of
25 cases (24%) was highlighted. Episodes of laryngeal aspiration/
penetration were reported in 4 out of 25 subjects (16%), while
episodes of nasal regurgitation in 7 patients (28% of the cases).
Concerning the presence of food consistency restrictions, we found
restriction in 1 food consistency (solid) in 5 of 25 subjects (20%), and
in 2 or 3 consistencies in 2 (8%). Finally, about respiratory pattern in
our patients, 5 out of 25 subjects (20%) were mouth breathers, and
8 out of 25 (32%) were mixed breathers.
Instrumental investigations were carried out to better character-
ize the patients. Bilateral type B tympanogram was found in 5 out of
25 subjects (20%), unilateral type B in 1 (4%), bilateral type C in
1 (4%), and bilateral type A tympanogram in the remaining 18 patients
(72%). Audiometry revealed mild bilateral conductive hearing loss
(25–40 dB) in 7 patients (28%), mild unilateral conductive hearing loss
(25–40 dB) in 1 (4%), bilateral normoacusia in 17 patients (68%).
Videofluoroscopy was normal in 21 patients (84%); the exam showed
hypopharyngeal residues after swallowing in 2 cases (8%), and
nasal regurgitation with or without hypopharyngeal residues after
swallowing in other 2 cases (8%).
Statistical analysis to identify an association between the anatom-
ical, functional as well as instrumental alterations of otolaryngologic
phenotype is illustrated in Tables 3 and 4. As illustrated in Table 3,
TABLE 1 Main descriptive data of the cohort of 22q11.2DS patients
No. of patients 25
Age (years) (Median [range]) 10.0 (4–21)
Male (%) 64
Complete DiGeorge syndrome (%) 0
ENT anomalies (%) 88
ENT surgery (%) 20
Speech therapy (%) 60
Congenital cardiac defects (%) 76
Hypoparathyroidism (%) 12
TABLE 2 Frequency of ENT features in the cohort of patients
n %
Previous surgery
No surgery 20 80
Submucous cleft palate 2 8
Cleft velum 2 8
Cleft palate 1 4
Palatal classification
No anatomical and functional anomalies 4 16
Minimal anomalies (occult submucous
cleft)
14 56
Minor anomalies with palatal
hypomotility
5 20
Major anomalies with absent motility 2 8
Nasal air emission
No air emission on pressure sensitive
sounds
12 48
Audible inconsistent nasal emission 7 28
Audible consistent nasal emission 6 24
Inaudible nasal emission 0 0
Rhinolalia/rhinophonia classification
Normal articulation without appreciable
alterations of resonance
13 52
Some typical slight articulatory defects
with mild/moderate open rhinophonia
7 28
Typical and consistent articulatory




Tonsils not exceeding the pillars (0%) 13 52
Tonsils up to 50% of the space between
loggia and median line
10 40
Tonsils up to 75% 2 8
Tonsils up to 100% 0 0
Adenoids volume
Adenoids occupying up to 25% of the
nasopharynx
5 20
Adenoids occupying up to 50% 15 60
Adenoids occupying up to 75% 5 20




Normal tympanic membrane on both
sides
16 64
Bilateral retracted tympanic membrane 8 32
Bilateral tympanic effusion 1 4
Tympanogram
Type A bilaterally 18 72
Type C bilaterally 1 4
Type A on one side and type B on the
other
1 4
Type B bilaterally 5 20
Hearing
Normal hearing (<25 dB) 17 68
Mild monolateral conductive hypoacusia
(25–40 dB)
1 4
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a significant association between the severity of palatal anomalies
requiring surgery and the degree of rhinolalia/phonia (p = .017), as
well as between the severity of palatal anomalies requiring surgery
and nasal air emission (p = .012) was found. As expected, a correlation
was also found when palatal abnormalities degree was compared
with the degree of rhinolalia/phonia (p < .0005) and with nasal air
emission (p < .0005). Rhinolalia/phonia grading also correlated with
the presence of episodes suggesting laryngeal aspiration/penetration
(p = 0.016) and with severity of food restriction (p = .001). There
was also a correlation between episodes of nasal regurgitation and
of laryngeal aspiration/penetration (p = .009). In addition, food restric-
tions were significantly associated with nasal air emission (p = .007),
with nasal regurgitation episodes (p < .0005), with the presence of
episodes of laryngeal penetration/aspiration (p < .0005), and with
mouth breathing pattern (p = 0.019). As illustrated in Table 4, the tym-
panometric pattern correlated, as expected, with the abnormal oto-
scopic findings (p = .022) and with the adenoid volume (p = .044);
there was also an association with mouth respiratory pattern
(p = .023). Similarly, the more severe audiometric anomalies the more
profound abnormal respiratory pattern (p = .003) was noted. Eventu-
ally, the abnormal transit of the bolus, detected at videofluoroscopy,
correlated with episodes of laryngeal aspiration/penetration
(p = .016), with a linear progression.
We also studied the immunophenotype in our cohort of subjects.
Lymphopenia affected 4 of 25 patients (16%). Nine of the 25 patients
(36%) had a reduced number of CD4+ cells compared to normal range
for age. Eleven out of 25 (44%) and 4 out of 25 (16%) patients had a
reduced number of CD8+ or CD19+ cells, respectively. About serum
levels of immunoglobulin of our 25 patients, 1 (4%) had a reduced
serum concentration of IgA, 8 (32%) had reduced levels of IgM, and
1 (4%) patient had reduced concentration of IgG compared to normal
range for age. All subjects produced isohemagglutinins and antigen-
specific antibodies following immunization.
The mean (SD) of the number of respiratory infections in the






Episodes of laryngeal aspiration/
penetration
No current or previous disorder 21 84
Previous episodic disorders 3 12
Previous and current episodic disorders 1 4
Episodes of nasal regurgitation
No current or previous disorder 18 72
Previous episodic disorders 4 8
Previous and current episodic disorders 3 12
Swallowing anomalies












No restrictions 18 72
In 1 consistency 5 20
In 2 or 3 consistencies 2 8
Abbreviation: n, absolute number of patients per feature.
TABLE 3 Univariate analysis. Relationships between anatomic and










Spearman’s rho 0.472 0.494 0.117
p value .017 .012 .578
Minor palatal abnormalities
Spearman’s rho 0.754 0.746 0.288
p value .000 .000 .163
Episodes of laryngeal P/A
Spearman’s rho 0.476 0.328 0.511
p value .016 .110 .009
Food restrictions
Spearman’s rho 0.604 0.522 0.680
p value .001 .007 .000
Abbreviation: P/A, penetration/aspiration.
TABLE 4 Univariate analysis. Relationships between instrumental ENT variables and anatomic-functional ENT variables in our cohort of subjects
Otoscopic anomalies Adenoid volume Respiratory pattern Episodes of laryngeal P/A
Tympanometric anomalies
Spearman’s rho 0.457 0.407 0.453 −0.020
p value .022 .044 .023 .925
Audiometric alteration
Spearman’s rho 0.382 0.280 0.571 0.204
p value .059 .176 .003 .327
Videofluoroscopic pattern
Spearman’s rho 0.073 0.000 0.078 0.475
p value .728 1.000 .709 .016
Abbreviation: P/A, penetration/aspiration.
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them had a number of infections greater than 6 and only 3 of them
experienced at least 1 episode of otitis during the observation period.
No statistically significant association was observed between the
number of infections and the ENT findings already mentioned.
Moreover, there was no association between infections and immuno-
phenotypic findings.
To find a correlation between the age of the subjects and the var-
iables under examination, we performed a Spearman rank correlation
test between age and all ENT findings and between age and the num-
ber of infections in the last 24 months. We found a significant nega-
tive correlation between age and adenoid volume (p < .005) or
tonsillar volume (p = .029); no correlation between age and the other
ENT findings, neither between age and the number of infections, was
found.
As shown in the Figure 1, using the Pearson correlation test, we
observed a direct correlation between lymphocyte cells count and the
severity of audiometric alteration (p = .007) and the palatine tonsils
volume (p = .013).
We next performed multivariate analysis (namely factor analysis)
to obtain information about the interdependency between the
observed variables in our cohort of 22q11.2DS patients. As detailed in
the Figure 2, we found six clusters of variables (defined as compo-
nents), where a few variables are correlated one to each other. In par-
ticular, as illustrated in the Figure 2B, four of them are represented by
functional and anatomical ENT features. The first ENT cluster includes
variables related to swallowing disturbances, namely food restriction,
episodes of nasal regurgitation, or laryngeal penetration/aspiration;
the second one includes variables related to speech disturbance, such
FIGURE 1 Univariate analysis. Box plots show the distribution of the variable “Lymphocyte cells count” in our cohort of patients, using like
grouping variables “audiometry” and “Palatine tonsils volume”. The analyses suggest positive association between “lymphocyte count” and the
two variables (p = .007, p = .013, respectively) [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 2 Multivariate analysis. All components with eigenvalues under 1.5 were dropped. Varimax rotation method was used. Factor loadings
in multivariate analysis, including all the variables are illustrated in the right part of the figure. Factor analysis shows that within each factor there
are clusters of variables, which are positively correlated one to each other
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as nasal air emission, rhinolalia/phonia grading, and minor palatal
abnormalities; the third and the fourth group concern otological and
upper respiratory tract disturbances, being represented by tympano-
metric alterations and severity of conductive hearing loss or by ade-
noid volume, and mouth breathing pattern, respectively. Further, two
clusters refer to immunological parameters.
4 | DISCUSSION
Otolaryngologic manifestations are quite common in 22q11.2DS and,
in particular in subjects with a mild phenotype, can represent one of
the clinical features for which the patient is referred to the physician. A
better characterization of ENT abnormalities and the understanding of
the relationship between these and other aspects of the clinical pheno-
type of the syndrome are therefore necessary. We examined at a single
Center a cohort of 25 patients diagnosed as 22q11.2DS and found that
88% of the subjects had otolaryngologic anomalies. The prevalence of
cleft palate requiring surgery in our cohort (including submucous cleft
palate, cleft velum, and cleft palate) was 20%, while the prevalence of
palatal anomalies in length and/or mobility was 28%. In addition, we
observed a high prevalence of minimal palatal abnormalities, largely cor-
responding to cases of occult submucous cleft palate (56%). Overall,
palatal anomalies affected 84% of the subjects and positively correlate
with episodes of nasal regurgitation, nasal air emission, and articulatory
defects. Thus far, a specific approach for the clinical management of
such problems is not yet well defined.
In the present study, it was found that in 48% of the patients ton-
sils exceeded the pillars and in 80% adenoids occupied more than
25% of nasopharynx. Comparing these data with those reported in a
healthy pediatric population (Akcay, Kara, Dagdeviren, & Zencir,
2006; Wang, Bernheim, Kaufman, & Clement, 1997), the adenoid and
tonsillar size in our cohort are generally higher. This finding was unex-
pected, since previous studies (Ford et al., 2000; Ruotolo et al., 2006)
documented a reduced volume of tonsils and adenoids in patients
with 22q11.2DS, compared with the general population, it being
interpreted as a potential cause of the velopharyngeal incompetence.
Rhinolalia/phonia, already described as a feature of 22q11.2DS
(McDonald-McGinn et al., 1999), was also found in 52% of our cohort
of patients, and in 24% a severe articulation defect was documented;
moreover, the severity of rhinolalia/phonia correlated with palate
abnormalities, as well as with food restriction, and with episodes of
laryngeal penetration/aspiration. This indicates that a videofluoro-
scopic swallowing study in patients with articulation defects would
help manage such patients in early detecting bolus transit abnormali-
ties. This could also pave the way to set up strategies to prevent asso-
ciated complications, as ab ingestis pneumonitis. Furthermore, the
early adoption of a specific speech therapy program could be helpful
in improving the overall quality of life of such patients (Speyer,
Baijens, Heijnen, & Zwijnenberg, 2010).
No association was observed between episodes of nasal regurgi-
tation and palate anomalies (including major and minor abnormalities),
nor between the latter and episodes of laryngeal penetration/aspira-
tion, which are different from what is observed in patients not
affected with 22q11.2DS with palate abnormalities, in whom a
positive correlation was found (Walter, Nisa, & Leuchter, 2013). This
finding would suggest that further factors, as dysmorphic features or
muscular dysmotility, may be implicated in the pathogenesis of
dysphagia and nasal regurgitation associated with 22q11.2DS.
The instrumental study of the acoustic function was performed by
audiometry and timpanometry. The results appear to be substantially in
line with those described in larger studies (Van Eynde et al., 2016;
Verheij et al., 2017). Statistical analysis showed that abnormal timpano-
metric findings were directly related to the audiometric and otoscopic
alterations, and with the adenoid volume, as well. These data suggest
that a careful management of adenoid hypertrophy should be consid-
ered to prevent tympanometric alterations in patients with 22q11.2DS.
Regarding the respiratory pattern, there was an interdependence
between mouth breathing and increased adenoid volume. This observa-
tion would favor the hypothesis that adenoid hypertrophy could play a
cause role in determining the respiratory pattern of patients with
22q11.2DS, whereas, previously, a significant role was attributed to the
neurological status or to the narrow nasal vault (Ford et al., 2000).
Eventually, although we could not find any association between
the ENT findings and the number of infections of the ENT region and
of lower respiratory tract, we cannot conclusively rule out that ENT
abnormalities may have a role in favoring infections due to the limited
number of patients studied. In particular, only 12% of them had at
least one episode of otitis during the observation time. A possible
explanation is that the majority of the enrolled subjects (65%) were
older than 8 years. A multicentric study, enrolling a larger cohort of
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